Risk Warning: This token has undergone changes to its tokenomics. Token supply has increased, please pay attention to the potential risk . DYOR

- Solana's 30% price drop in late 2025 contrasts with strong on-chain metrics like 400ms finality and $35.9B DEX volume, but declining user engagement and rising NVT ratios signaled overvaluation. - Macroeconomic factors including high interest rates and institutional caution reduced speculative demand, with ETF inflows favoring staking products over direct price support. - Whale accumulation and RWA growth (up 350% YoY) suggest strategic buying during dips, though active address recovery and NVT normaliza

- Global dementia cases surge to 55M in 2025, projected to triple to 139M by 2050 due to aging populations and Alzheimer's rise. - U.S. dementia costs hit $781B in 2025, with Medicare/Medicaid covering $164B and families paying $52B out-of-pocket. - Home healthcare and AI caregiver tech markets grow rapidly (10-17% CAGR), reaching $381B and $5.3B by 2033-2032 respectively. - Dementia biotech faces risks but attracts $3.1B in Q3 2025 venture funding (+70.9% QoQ), despite $161M losses at Alector/Denali. - St

- Q3 2025 saw record $73.59B in crypto leverage, with $19B wiped in single-day Bitcoin liquidations on Oct 10. - Over-leveraging driven by FOMO and social media hype triggered panic selling via ADL mechanisms on major exchanges. - Automated risk controls prevented insolvency but exposed systemic fragility amid rapid price swings and emotional trading. - Experts urge retail investors to adopt strict leverage limits, stop-loss orders, and AI-driven analytics for disciplined risk management. - Regulatory scru